Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, above historical average.
Left:
||||
Free cash flow yield
Latest
3.40%
↑ 155% above average
Average (9y)
-6.20%
Historical baseline
Range
High:6.09%
Low:-26.05%
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2025 | 3.40% | +113.1% |
| 2024 | -26.05% | -127.2% |
| 2023 | -11.47% | -111.5% |
| 2022 | -5.42% | -337.8% |
| 2021 | 2.28% | +192.1% |
| 2020 | -2.48% | -140.7% |
| 2019 | 6.09% | +301.1% |
| 2018 | -3.03% | +69.9% |
| 2017 | -10.06% | +34.0% |
| 2016 | -15.23% | - |